/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.09%
Natural Gas
-0.29%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.53%
VIX
N/A
Economic Calendar
EUR/USD
+0.09%
Natural Gas
-0.29%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-1.53%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
US GDP Growth Starts 2024 Below Expectations
about 2 hours ago
German GfK Consumer Climate Indicator Climbs to -24.2 for May
about 8 hours ago
Nasdaq Tumbles as Meta Sparks Renewed Tech Beating
about 10 hours ago
Crude Inventories Fall By 6.4 Million Barrels
about 24 hours ago
Durable Goods Orders Exceed Market Expectations; Core Orders Miss
about 23 hours ago
German Ifo Business Climate Index Rises to 89.4 in April
1 day ago
S&P 500 Price Forecast – S&P 500 Continues to See Support
about 1 hour ago
NASDAQ 100 Price Forecast – NASDAQ 100 Continues to Stabilize
about 1 hour ago
Gold Price Forecast – Gold Continues to Look Supported
37 minutes ago
EUR/USD Forecast – Euro Continues to See Momentum
about 1 hour ago
AUD/USD Forecast – Aussie Continues to Attempt a Move Higher
about 1 hour ago
Natural Gas News: Analysts Predict Significant Inventory Build in EIA Report
about 2 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
APLS
news
Apellis Pharmaceuticals Inc
Follow
APLS
(
Nasdaq - US
)
N/A
48.33
-1.60 (-3.20%)
in
:
usd
•
As of: Apr 25, 2024 10:21
UTC -4
Open
49.34
High
49.34
Low
48.19
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Zacks Investment Research
Feb 28, 2024
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
APLS
-3.20%
Seeking Alpha
Feb 27, 2024
Apellis Pharmaceuticals, Inc. (APLS) Q4 and Full Year 2023 Earnings Call Transcript
APLS
-3.20%
Zacks Investment Research
Feb 27, 2024
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Earnings: What Key Metrics Have to Say
APLS
-3.20%
Zacks Investment Research
Feb 27, 2024
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates
APLS
-3.20%
Zacks Investment Research
Feb 26, 2024
5 Stocks to Buy That Are Poised to Beat on Earnings This Week
APLS
-3.20%
CEG
+0.78%
Zacks Investment Research
Feb 23, 2024
Why Apellis (APLS) Might Surprise This Earnings Season
APLS
-3.20%
Zacks Investment Research
Feb 20, 2024
Apellis Pharmaceuticals, Inc. (APLS) Upgraded to Buy: Here's What You Should Know
APLS
-3.20%
Zacks Investment Research
Feb 14, 2024
Has Apellis Pharmaceuticals (APLS) Outpaced Other Medical Stocks This Year?
APLS
-3.20%
Zacks Investment Research
Feb 13, 2024
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
APLS
-3.20%
Zacks Investment Research
Jan 29, 2024
Apellis (APLS) Down on Negative CHMP Opinion for Pegcetacoplan
APLS
-3.20%
Zacks Investment Research
Jan 12, 2024
Apellis (APLS): Strong Industry, Solid Earnings Estimate Revisions
APLS
-3.20%
Zacks Investment Research
Jan 9, 2024
Apellis (APLS) Up on Strong Q4 Preliminary Syfovre U.S. Revenues
APLS
-3.20%
Zacks Investment Research
Jan 9, 2024
Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?
APLS
-3.20%
Zacks Investment Research
Dec 15, 2023
Apellis (APLS) Falls on Europe Update for Pegcetacoplan in GA
APLS
-3.20%
Investors Business Daily
Dec 14, 2023
Apellis Crashes 21% As It Stares Down A Likely European Rejection
APLS
-3.20%
Market Watch
Dec 14, 2023
Apellis Pharmaceuticals' stock slides 14% after company gets negative trend vote for eye treatment in Europe
APLS
-3.20%
Zacks Investment Research
Dec 4, 2023
Apellis (APLS) Rides on Syfovre to Fuel Growth Amid Rivalry
APLS
-3.20%
Zacks Investment Research
Dec 1, 2023
Apellis Pharmaceuticals, Inc. (APLS) Up 9.2% Since Last Earnings Report: Can It Continue?
APLS
-3.20%
Zacks Investment Research
Nov 2, 2023
Apellis (APLS) Q3 Loss Wider Than Expected, Syfovre Drives Sales
APLS
-3.20%
Seeking Alpha
Nov 1, 2023
Apellis Pharmaceuticals, Inc. (APLS) Q3 2023 Earnings Call Transcript
APLS
-3.20%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker